| Descriptor English: | Diminazene | ||||||
| Descriptor Spanish: |
Diminazeno
| ||||||
| Descriptor Portuguese: | Diminazena | ||||||
| Descriptor French: | Diminazène | ||||||
| Entry term(s): |
4,4' Diazoaminobenzamidine 4,4'-Diazoaminobenzamidine |
||||||
| Tree number(s): |
D02.078.100.260 D02.925.240 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004133 | ||||||
| Scope note: | An effective trypanocidal agent. |
||||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
| Pharm Action: |
Trypanocidal Agents |
||||||
| Registry Number: | Y5G36EEA5Z | ||||||
| CAS Type 1 Name: | Benzenecarboximidamide, 4,4'-(1-triazene-1,3-diyl)bis- | ||||||
| Previous Indexing: |
Amidines (1969-1974) Triazenes (1974) |
||||||
| Public MeSH Note: | 91; was see under AMIDINES 1975-90 |
||||||
| History Note: | 91(75); was see under AMIDINES 1975-90 |
||||||
| DeCS ID: | 4185 | ||||||
| Unique ID: | D004133 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1991/01/01 | ||||||
| Date of Entry: | 1974/11/19 | ||||||
| Revision Date: | 2013/07/08 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
|
Diminazene
- Preferred
| Concept UI |
M0006470 |
| Scope note | An effective trypanocidal agent. |
| Preferred term | Diminazene |
| Entry term(s) |
4,4' Diazoaminobenzamidine 4,4'-Diazoaminobenzamidine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
